Acarbose
- Product NDC
- 43353-951
- 11-digit product format
- 433530951
- Labeler code
- 43353
- Product ID
- 43353-951_d644a3db-506a-4d45-9cd3-519871c90eb2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acarbose
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA020482
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2008-01-30
- Marketing end
- 0000-00-00
- Substance
- ACARBOSE
- Active strength
- 50 mg/1
- Pharmacologic classes
- alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-951 | ACARBOSE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20160706_6fb339f5-a3c5-4069-bd39-fc2c28e677ea.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-951-09 | 43353095109 | 9000 TABLET in 1 BOTTLE (43353-951-09) | 9000 tablet | 2014-06-13 | 0000-00-00 | No | No | Current |